Phase 2 Granulomatosis With Polyangiitis Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss Syndrome
NS Pharma, Inc.45 enrolled34 locationsNCT06046222
Recruiting
Phase 2
Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis
Granulomatosis With Polyangiitis
Assistance Publique - Hôpitaux de Paris33 enrolled1 locationNCT06940661
Recruiting
Phase 2Phase 3
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
Eosinophilic Granulomatosis With Polyangiitis
Guangdong Hengrui Pharmaceutical Co., Ltd166 enrolled2 locationsNCT05979051